Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Thursday, September 22, 2022

Dynamic nomogram for predicting acute kidney injury in patients with acute ischemic stroke: A retrospective study

 And somehow in your two functioning brain cells you think predicting damage rather than preventing such damage was worthwhile research?

Dynamic nomogram for predicting acute kidney injury in patients with acute ischemic stroke: A retrospective study

Ganggui Zhu1, Zaixiang Fu2, Taian Jin2, Xiaohui Xu3, Jie Wei2, Lingxin Cai2 and Wenhua Yu1*
  • 1Department of Neurosurgery, Hangzhou First People's Hospital, School of Medicine, Zhejiang University, Hangzhou, China
  • 2Department of Neurosurgery, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou, China
  • 3Department of Neurosurgery, The Fourth Affiliated Hospital, School of Medicine, Zhejiang University, Yiwu, China

Background: This study sought to develop and validate a dynamic nomogram chart to assess the risk of acute kidney injury (AKI) in patients with acute ischemic stroke (AIS).

Methods: These data were drawn from the Medical Information Mart for Intensive Care III (MIMIC-III) database, which collects 47 clinical indicators of patients after admission to the hospital. The primary outcome indicator was the occurrence of AKI within 48 h of intensive care unit (ICU) admission. Independent risk factors for AKI were screened from the training set using univariate and multifactorial logistic regression analyses. Multiple logistic regression models were developed, and nomograms were plotted and validated in an internal validation set. Based on the receiver operating characteristic (ROC) curve, calibration curve, and decision curve analysis (DCA) to estimate the performance of this nomogram.

Results: Nomogram indicators include blood urea nitrogen (BUN), creatinine, red blood cell distribution width (RDW), heart rate (HR), Oxford Acute Severity of Illness Score (OASIS), the history of congestive heart failure (CHF), the use of vancomycin, contrast agent, and mannitol. The predictive model displayed well discrimination with the area under the ROC curve values of 0.8529 and 0.8598 for the training set and the validator, respectively. Calibration curves revealed favorable concordance between the actual and predicted incidence of AKI (p > 0.05). DCA indicates the excellent net clinical benefit of nomogram in predicting AKI.

Conclusion: In summary, we explored the incidence of AKI in patients with AIS during ICU stay and developed a predictive model to help clinical decision-making.

Introduction

Stroke remains the second most common disease threatening humans worldwide (1). Stroke places a tremendous burden on patients, families, and society, especially in developing countries (2). The American Heart Association and the American Stroke Association project that the total medical cost of stroke will reach $1,841 billion from 2012 to 2030 (3). Ischemic stroke, usually caused by a blood clot blocking an artery in the brain, is the leading type of stroke (4). Tissue plasminogen activator (tPA) is the only drug currently approved by the United States Food and Drug Administration (FDA) for the treatment of ischemic strokes. Patients outside of the time window for tPA use may be treated with other therapies, such as thrombectomy, anticoagulants, blood pressure-lowering, and cholesterol-lowering drugs. Nevertheless, the effectiveness of treatment for ischemic stroke is unsatisfactory. Stroke kills ~6 million people each year, accounting for more than 10% of all deaths (5). Therefore, in the management of ischemic stroke, early identification of patients who may have a poor prognosis and timely intervention is important to improve the quality of patient survival later in life.

Acute kidney injury (AKI) is a common condition in critically ill patients and occurs in ~30–50% of intensive care unit (ICU) patients (6). High mortality is one of its characteristics, with ~20–25% of patients dying during hospitalization (7, 8). AKI manifests itself as a dramatic deterioration of renal function and a decrease in urine output, which leads to water and electrolyte disturbances and high circulating blood volume, resulting in a series of negative effects on other organs (9). After the stroke, activation of the sympathetic nervous system, the renin-angiotensin-aldosterone pathway impairs the self-regulatory function of the kidney (10). Moreover, the immune response induced by stroke leads to a massive release of inflammatory factors, resulting in decreased renal function (11). Therefore, early identification, recognition, and intervention can reduce the probability of AKI and slow down its progression (12).

However, there are no validated clinical models to predict the occurrence of AKI in patients with acute ischemic stroke (AIS). Therefore, there is a need to effectively predict the occurrence of AKI or screen for potential risk factors to guide early clinical intervention to improve prognosis. Based on several key variables and parameters, nomograms, especially dynamic nomograms, provide a powerful and easy-to-use method to predict the outcomes of individual events (1316). The main objective of this study was to identify factors that independently predict the occurrence of AKI in patients with AIS. The patient cohort and factors were selected from the Medical Information Mart for Intensive Care III (MIMIC-III) database, and the nomogram was concurrently developed to predict the incidence of AKI in the AIS population during ICU (17).

More at link.

No comments:

Post a Comment